Liquidia LQDA
NASDAQ LQDA
$68.50 +0.82 (+1.20%)
As of: Sep 9, 2026 · 1:03 PM EDT

Liquidia (LQDA) Interest & Investment Income (2020 - 2026)

Liquidia (LQDA) posted Interest & Investment Income of $2.5 million for Q2 2026, up 39.73% on a QoQ basis from $1.8 million in Q1 2026, and up 56.31% year-over-year from $1.6 million in Q2 2025.

Analysis

Liquidia (LQDA) Interest & Investment Income (2020 - 2026) Analysis & Trends

Liquidia has reported Interest & Investment Income for 7 years, with the latest figure at $2.5 million in Q2 2026.

  • On a quarterly basis, Interest & Investment Income rose 56.31% year-over-year to $2.5 million in Q2 2026; TTM through Jun 2026 was $7.6 million, a 4.55% increase from a year earlier, with the FY2025 full-year figure at $6.6 million, down 13.46% from the prior year.
  • Interest & Investment Income was $2.5 million for Q2 2026 at Liquidia, up from $1.8 million in the prior quarter.
  • The five-year high for Interest & Investment Income was $2.5 million in Q2 2026, with the low at $4000.0 in Q1 2022.
  • Average Interest & Investment Income over 5 years is $1.3 million, with a median of $1.6 million recorded in 2025.
  • The sharpest annual moves came in 2022 and 2023: Interest & Investment Income tumbled 80.95% in 2022, then soared 22950.0% in 2023.
  • Over 5 years, Interest & Investment Income stood at $662000.0 in 2022, then jumped by 43.2% to $948000.0 in 2023, then soared by 121.94% to $2.1 million in 2024, then slipped by 20.77% to $1.7 million in 2025, then jumped by 48.53% to $2.5 million in 2026.
  • The last three Interest & Investment Income figures came in at $2.5 million (Q2 2026), $1.8 million (Q1 2026), and $1.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Johnson & Johnson 643.50 Bn 622.74 Bn 17.26 Bn 219.00 Mn
2 AbbVie 440.29 Bn 433.72 Bn 12.70 Bn -679.00 Mn
3 Merck 364.93 Bn 357.79 Bn 12.21 Bn -
4 Novartis Ag 266.65 Bn 258.96 Bn 11.24 Bn -
5 Pfizer 158.92 Bn 147.22 Bn 10.94 Bn -
6 Sanofi 52.46 Bn 45.08 Bn 10.79 Bn 89.50 Mn
7 Revolution Medicines 44.32 Bn 44.32 Bn - 35.58 Mn
8 Incyte 25.32 Bn 20.78 Bn 1.57 Bn 38.12 Mn
9 United Therapeutics 21.42 Bn 18.75 Bn 683.80 Mn 31.50 Mn
10 Liquidia 6.09 Bn 5.80 Bn 160.92 Mn 2.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.48 Mn
Mar 31, 2026 1.77 Mn
Dec 31, 2025 1.67 Mn
Sep 30, 2025 1.65 Mn
Jun 30, 2025 1.58 Mn
Mar 31, 2025 1.73 Mn
Dec 31, 2024 2.10 Mn
Sep 30, 2024 1.82 Mn
Jun 30, 2024 1.86 Mn
Mar 31, 2024 1.88 Mn
Dec 31, 2023 948,000.00
Sep 30, 2023 862,000.00
Jun 30, 2023 734,000.00
Mar 31, 2023 922,000.00
Dec 31, 2022 662,000.00
Sep 30, 2022 359,000.00
Jun 30, 2022 65,000.00
Mar 31, 2022 4,000.00
Dec 31, 2021 3,000.00
Sep 30, 2021 4,000.00